LEELAWATTIE BISNAUTH: Open Payments
NPI 1912583337 · YORKTOWN, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$767 in 40 payments from 15 companies in 2025. Trend: 2023 $201 · 2024 $913 · 2025 $767
Food & beverage: $767
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 7 | $144 |
| ABBVIE INC. | 5 | $112 |
| GlaxoSmithKline, LLC. | 4 | $91 |
| PFIZER INC. | 5 | $89 |
| Lilly USA, LLC | 4 | $77 |
| Amgen Inc. | 3 | $46 |
| Merck Sharp & Dohme LLC | 2 | $37 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $32 |
| AstraZeneca Pharmaceuticals LP | 2 | $31 |
| Exact Sciences Corporation | 1 | $23 |
Products named: QULIPTA, MOUNJARO, TRELEGY ELLIPTA, NURTEC ODT, Ozempic, JARDIANCE, EVENITY, AIRSUPRA.
Industry payments across VA — which companies pay providers there.
